Lattice intrahepatic doxorubicin with and without in-flow occlusion: A pharmacokinetic study of direct liver injection

European Journal of Surgical Oncology

Volumn 26, Issue 1, 2000, Pages 73-79

  Averbach, A ^b   Stuart, O A ^a   Chang, D ^c   Sugarbaker, P H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b ST AGNES HOSPITAL   (United States)

^c WESTAT   (United States)

Author keywords

Colorectal liver metastases; Doxorubicin; Hepatoma; In flow occlusion; Intrahepatic chemotherapy; Pharmacokinetics

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD SAMPLING; COMMON BILE DUCT; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; FEMALE; HEPATIC ARTERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER BIOPSY; LIVER CANCER; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL;

EID: 0033974429     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0744     Document Type: Article

References (15)

1. Sullivan RD, Zurek WZ. Chemotherapy for liver cancer by protracted ambulatory infusion. JAMA. 194:1965;481-486.
2. Bern MM, McDermott W, Jr, Cady B, Oberfield RA, Trey C, Clouse ME, Tullis JL, Parker LM. Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report. Cancer. 42:1978;399-405.
3. Garnick MB, Ensminger WD, Israel M. A clinical- pharmacological evaluation of hepatic arterial infusion of adriamycin. Cancer Res. 39:1979;4105-4110.
4. Raoul J, Heresback D, Bretagne JF, Bentue Ferrer D, Duvauferrier R, Bourguet P, Messner M, Gosselin M. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer. 70:1992;585-590.
5. Ravikumar TS, Pizzorno G, Bodden W, Marsh J, Strair R, Pollack J, Hendler R, Hanna J, D'Andrea E. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol. 12:1994;2723-2736.
6. Ku Y, Fukumoto T, Iwasaki T. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemo- perfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery. 117:1995;510-519.
7. Ku Y, Fukumoto T, Tominaga M. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. Am J Surg. 173:1997;103-109.
8. Jain RK. Therapeutic implications of tumor physiology. Curr Opin Oncol. 3:1991;1105-1108.
9. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluoro-deoxyuridine chemo- therapy in the treatment of colorectal liver metastases. Ann Surg. 206:1987;685-693.
10. Pringle JH. Notes on the arrest of hepatic hemmorhage due to trauma. Ann Surg. 48:1908;541-549.
11. Jacquet P, Averbach A, Stuart OA, Chang D, Sugarbaker PH. Hyperthermic intra-peritoneal doxorubicin: Pharmacokinetics, metabolism and distribution in rat model. Cancer Chemother Pharmacol. 41:1998;147-154.
12. Israel M, Pegg WJ, Wilkinson PM, Garnick MB. Liquid chromatographic analysis of adriamycin and metabolites in biological fluids. J Liquid Chromatogr. 1:1978;795-809.
13. Ensminger WD. Regional therapy. Sem Oncol. 20:1993;3-11.
14. Jain RK, Weissbrod J, Wei J. Mass transfer in tumors: characterization and applications in chemotherapy. Adv Cancer Res. 33:1980;241-310.
15. Shiina S, Tagawa K, Unuma T. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histo- pathologic study. Cancer. 68:1991;1524-1530.